 Echocardiographic findings hemodialysis patients recombinant human erythropoietin proposal hematocrit beneficial hemodynamics hemodynamic effects correction anemia recombinant human erythropoietin rHuEPO hemodialysis patients severe anemia Echocardiograms administration rHuEPO period hematocrit mean SD periods II III hematocrit Left ventricular end-diastolic dimension LVDd mm changes left ventricular end-systolic dimension Cardiac output CO l/min thickness interventricular septum left ventricular posterior wall unchanged Blood pressure constant antihypertensive therapy occurrence aggravation hypertension Total peripheral resistance decreases LVDd CO significant periods II changes periods II III antihypertensive therapy period III period II Similar echocardiographic results patients antihypertensive therapy study conclusion increase hematocrit appropriate order effective hemodynamic improvement rHuEPO therapy dialysis patients hematocrit level desirable order capacity